DiaSorin S.p.A. (DSRLF) Q2 2026 Earnings Call Transcript

SA Transcripts 161.4K Followers Follow DiaSorin S.p.A. ( DSRLF ) Q2 2026 Earnings Call July 31, 2026 9:00 AM EDT Company Participants Carlo Rosa - CEO, GM & Executive Director Alberto Donati - Chief Financial Officer Conference Call Participants Aisyah Noor - Morgan Stanley, Research Division David Westenberg - Piper Sandler & Co., Research Division Anchal Verma - JPMorgan Chase & Co, Research Division Anna Ractliffe - BofA Securities, Research Division Charles Pitman - Barclays Bank PLC, Research Division Odysseas Manesiotis - BNP Paribas, Research Division Jan Koch - Deutsche Bank AG, Research Division Natalia Webster - RBC Capital Markets, Research Division Kavya Deshpande - UBS Investment Bank, Research Division Presentation Operator Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the DiaSorin Half Year 2026 Results Conference Call. [Operator Instructions] At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir. Carlo Rosa CEO, GM & Executive Director Thank you, operator. Good morning, good afternoon, and welcome to the second quarter conference call. As usual, I'm going to comment the results at constant exchange rate. And then our CFO, Mr. Donati, is going to take you through the numbers. So quarter 2, 2026 recorded a growth of 4%. And if actually we exclude outliers, China and molecular growth would have been 5%, molecular respiratory. And this is confirming the expected quarterly progression provided during the full year '25 results in March. If we look at the 3 technologies of DiaSorin the segments. Immunodiagnostics grew 4% in Q2, 5% ex China. Fundamentally, return to growth is supported by double-digit performance in the U.S. as we have discussed during the Q1 results. Quarter 1 was actually affected by destocking on QuantiFERON plus weather conditions in the U.S. So the growth of 4% globally is driven by U.S. and it is also recording a normalization in Europe and the impact